Brief: Moberg Pharma: OncoZenge Secures About SEK 70 Mln In Financing Ahead Of Spin-Off And Separate Listing

Moberg Pharma AB (publ)

16/11/2020 14:04

Nov 16 (Reuters) - Moberg Pharma AB (publ)  MBPH.ST :
    * ONCOZENGE SECURES APPROXIMATELY SEK 70 MILLION IN
FINANCING
AHEAD OF SPIN-OFF AND SEPARATE LISTING
    * SUBSIDIARY ONCOZENGE HAS RECEIVED BINDING UNDERTAKINGS
REGARDING
A DIRECTED ISSUE OF SHARES OF SEK 10 MILLION AND A FULLY SECURED
RIGHTS ISSUE OF SHARES OF APPROXIMATELY SEK 60 MILLION
    * ONCOZENGE DIRECTED ISSUE OF ABOUT SEK 10 MILLION IS
EXPECTED TO
FINANCE PLANNED ACTIVITIES IN ONCOZENGE UNTIL START OF 2022
    * ONCOZENGE ALSO INTENDS TO CARRY OUT FULLY GUARANTEED
RIGHTS
ISSUE AIMED AT AROUND SEK 60 MILLION BEFORE COSTS

Source text for Eikon:  ID:nWkr958LB9 
Further company coverage:  MBPH.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))